» Articles » PMID: 35371775

Biphasic Peritoneal Mesothelioma: A Lethal Clinical Entity

Overview
Journal Cureus
Date 2022 Apr 4
PMID 35371775
Authors
Affiliations
Soon will be listed here.
Abstract

Mesotheliomas are a rare malignancy of the serosal membrane. Mainly it affects the pleural surfaces followed by the second most common location, "peritoneum." The disease follows an aggressive pattern of spread, and by the time the diagnosis is established, the condition significantly spreads to distant locations. Diagnosis of malignant peritoneal mesothelioma is typically made by tissue biopsy. The standard treatment is radical resection; however, patients have benefited from several other modalities. The current case report describes a unique case of malignant mesothelioma, biphasic peritoneal mesothelioma (BPM), which comprises less than 25% of all peritoneal mesotheliomas. The diagnosis and treatment do not differ from other subtypes; however, the prognosis is poor, and if untreated, the survival is typically less than six months.

Citing Articles

Biphasic Peritoneal Mesothelioma Is a Rare Tumor and a Diagnostic Challenge: A Case Report.

Subahi E, Fadul A, Mohamed A, Alsayed A, Ali E, Sayed S Cureus. 2024; 16(1):e51725.

PMID: 38318560 PMC: 10839407. DOI: 10.7759/cureus.51725.

References
1.
Fujishima F, Konosu-Fukaya S, Nabeshima K, McNamara K, Sakamoto K, Sakurada J . Histological and immunohistochemical characteristics and status studied by FISH in six incidentally detected cases of well-differentiated papillary mesothelioma of the peritoneum. Indian J Pathol Microbiol. 2021; 64(2):277-281. DOI: 10.4103/IJPM.IJPM_111_20. View

2.
Marchevsky A, LeStang N, Hiroshima K, Pelosi G, Attanoos R, Churg A . The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center. Hum Pathol. 2017; 67:160-168. DOI: 10.1016/j.humpath.2017.07.015. View

3.
Ghafoor A, Mian I, Wagner C, Mallory Y, Agra M, Morrow B . Phase 2 Study of Olaparib in Malignant Mesothelioma and Correlation of Efficacy With Germline or Somatic Mutations in Gene. JTO Clin Res Rep. 2021; 2(10):100231. PMC: 8502774. DOI: 10.1016/j.jtocrr.2021.100231. View

4.
Raptopoulos V . Peritoneal mesothelioma. Crit Rev Diagn Imaging. 1985; 24(4):293-328. View

5.
Mujahed T, Tazelaar H, Sukov W, Halling K, Davila J, Glass C . Malignant Peritoneal Mesothelioma Arising in Young Adults With Long-standing Indwelling Intra-abdominal Shunt Catheters. Am J Surg Pathol. 2020; 45(2):255-262. DOI: 10.1097/PAS.0000000000001574. View